A. Dirican Et Al. , "Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway," Clinical and Translational Oncology , vol.17, no.2, pp.145-151, 2015
Dirican, A. Et Al. 2015. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway. Clinical and Translational Oncology , vol.17, no.2 , 145-151.
Dirican, A., ATMACA İLHAN, H., Bozkurt, E., Erten, C., Karaca, B., & Uslu, R., (2015). Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway. Clinical and Translational Oncology , vol.17, no.2, 145-151.
Dirican, A. Et Al. "Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway," Clinical and Translational Oncology , vol.17, no.2, 145-151, 2015
Dirican, A. Et Al. "Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway." Clinical and Translational Oncology , vol.17, no.2, pp.145-151, 2015
Dirican, A. Et Al. (2015) . "Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway." Clinical and Translational Oncology , vol.17, no.2, pp.145-151.
@article{article, author={A. Dirican Et Al. }, title={Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway}, journal={Clinical and Translational Oncology}, year=2015, pages={145-151} }